# Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer

> **NCT06362421** · — · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Oropharyngeal Squamous Cell Carcinoma
- Human Papillomavirus Infection

## Interventions

- **GENETIC:** Pre-Radiation Dental Evaluation/Sample Collection
- **OTHER:** Pre-Study Visit
- **GENETIC:** Oral Medicine Consultation Visit/Sample Collection

## Key facts

- **NCT ID:** NCT06362421
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI not moving forward with study at our institution
- **Last updated:** 2025-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06362421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06362421, "Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06362421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*